Home › Research › Brain scans and imaging
[18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ et al.. Annals of neurology, 2018-02-06
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To use a cluster analysis of [ 18 F]AV-1451 tau-PET data to determine how subjects with Alzheimer's disease (AD) vary in the relative involvement of the entorhinal cortex and neocortex, and determine whether relative involvement of these two regions can help explain variability in age and clinical phenotype in AD. Methods We calculated [ 18 F]AV-1451 uptake in entorhinal cortex and neocortex in 62 amyloid-positive AD patients (39 typical and 23 atypical presentation). tau-PET (positron emission tomography) values were normalized to the cerebellum to create standard uptake value ratios (SUVRs). tau-PET SUVRs were log-transformed and clustered blinded to clinical information into three groups using K-median cluster analysis. Demographics, clinical phenotype, cognitive performance, and apolipoprotein e4 frequency were compared across clusters. Results The cluster analysis identified a cluster with low entorhinal and cortical uptake (E Lo /C Lo ), one with low entorhinal but high cortical uptake (E Lo /C Hi ), and one with high cortical and entorhinal uptake (E Hi /C Hi ). Clinical phenotype differed across clusters, with typical AD most commonly observed in the E Lo /C Lo and E Hi /C Hi clusters, and atypical AD most commonly observed in the E Lo /C Hi cluster. The E Lo /C Lo cluster had an older age at PET and onset than the other clusters. Apolipoprotein e4 frequency was lower in the E Lo /C Hi cluster. The E Hi /C Hi cluster had the worst memory impairment, whereas the E Lo /C Hi cluster had the worst impairment in nonmemory domains. Interpretation This study demonstrates considerable variability in [ 18 F]AV-1451 tau-PET uptake in AD, but shows that a straightforward clustering based on entorhinal and cortical uptake maps well onto age and clinical presentation in AD. Ann Neurol 2018 Ann Neurol 2018;83:248-257.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Whitwell, J. L., Graff-Radford, J., Tosakulwong, N., Weigand, S. D., Machulda, M., Senjem, M. L., et al. (2018). [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease. Annals of neurology. https://doi.org/10.1002/ana.25142
Vancouver
Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, et al. [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease. Annals of neurology. 2018. doi:10.1002/ana.25142. PMID: 29323751.
BibTeX
@article{whitwell2018-29323751,
author = {Whitwell, J. L. and Graff-Radford, J. and Tosakulwong, N. and Weigand, S. D. and Machulda, M. and Senjem, M. L. and Schwarz, C. G. and Spychalla, A. J. and others},
title = {{[18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease}},
journal = {Annals of neurology},
year = {2018},
doi = {10.1002/ana.25142},
pmid = {29323751},
url = {https://doi.org/10.1002/ana.25142}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results The cluster analysis identified a cluster with low entorhinal and cortical uptake (E Lo /C Lo ), one with low entorhinal but high cortical uptake (E Lo /C Hi ), and one with high cortical and entorhinal uptake (E Hi /C Hi ).
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported and studied in people because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 25 of the 58 points we could judge it on, which is 43 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Annals of neurology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 1 / 2 | Blinded or placebo-controlled (as stated in the record) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 29323751) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 25 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 25 of the 58 points we could judge it on is 43 out of 100. |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.